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Oral cavity metastases are extremely rare, and comprise 
1% of all mouth malignant neoplasms. Aim: to retrospectively 
analyze the incidence of maxillary metastases, and to trace 
its epidemiological behavior. Material and Methods: 
A retrospective study was done of the period between 
January 1980 and January 2000;the following indicators 
were reviewed: sex, age, site of the metastasis, site of the 
primary tumor, and the histological type of tumors in 10 
patients. Results: The prevalence was similar in males and 
females (05 cases - 50%); three cases presented in the 2nd 
and 4th decades of life (30 - 30%). About half of the cases of 
metastases occurred in the maxilla and half in the mandible. 
The thyroid and prostate glands were the most prevalent 
primary tumor sites for metastases (03 cases each); the 
adenocarcinoma histological type had the highest metastatic 
rate (50%). Conclusions: Metastasis of the jaws is very rare 
and may occur at any age in both the genders, where the 
prevalence is equal for each sex. The thyroid and prostate 
seem to be the most frequent sites of distance metastasis of 
the jaws; the adenocarcinoma is the most frequent histological 
type causing such metastases.
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INTRODUCTION
Metastases in the mouth are extremely rare; they 
comprise 1% of all malignant mouth neoplasms. They 
are located in the mandible in 80 to 90% of cases; 
maxillary metastases are less common. Many types of 
primary malignancies can produce mouth metastases; 
the most of these tumors are located in the breast, the 
prostate, the lungs, the thyroid gland and the kidneys; 
these primary tumors give rise to most bone metasta-
ses.1
Metastatic involvement of the mandible and ma-
xilla cause a variety of signs and symptoms. In some 
cases, patients may be asymptomatic, in which case the 
diagnosis is made as a radiological finding.
Mandibular and maxillary tumors cause signifi-
cant morphological and functional changes, due to their 
natural progression and local/regional involvement; in 
most cases, a multidisciplinary approach is required.2
The differential diagnosis of these neoplasms 
may be difficult. Laboratory exams, such as immunohis-
tochemistry, may provide some parameters depending 
on their accuracy. Paresthesia (unilateral, hypoesthesia 
or lower lip anesthesia), with or with no pain, may be 
the initial clinical manifestation in a significant percenta-
ge of mandibular bone lesions. Changes in sensitivity of 
the lower lip, even if there are no radiological findings, 
should alert specialists to think about the possibility of 
an initial stage metastasis.3
Bone metastases are relatively common findings 
in advanced carcinomas, especially those originating 
from primary breast, lung, thyroid, prostate and kidney 
tumors. In gnathic involvement, the mandible is the 
preferred site relative to the maxilla in a 4:1 proportion; 
its posterior portion is particularly involved, due to 
abundant vascular and hematopoietic tissue.3
The purpose of this study was to undertake a 
retrospective analysis of the incidence of maxillary 
metastases during a 20-year period in patients seen at 
a reference medical unit, and to investigate its epide-
miological behavior based on the sample data.
MATERIAL AND METHOD
We carried out a retrospective study from January 
of 1980 to December of 2000, comprising the patients 
seen and treated in the Head and Neck Surgery Ward 
of the Oncology Center - Centro de Oncologia (CEON) 
of the Oswaldo Cruz University Hospital (HUOC) - 
University of Pernambuco (UPE).
During this period, there were 190 recorded 
cases of head and neck bone tumors, of which ten 
patients (5.2%) had maxillary metastases. There were 
six female and four male patients aged between 13 
and 75 years (mean - 43 years). The metastasis site, 
the primary tumor site and the histological tumor type 
were investigated (Table 1).
The Research Ethics Committee of the said ins-
titution registered and approved this study (protocol 
nº 134707/07).
Table 1. Data of patients.
  
Patient     Gender  Age Site    Site of primary tumor    Histological type
1 F 13 Maxilla    Thyroid    Papillary adenocarcinoma 
2 F 64 Mandible      Thyroid    Follicular carcinoma
3 M 75 Mandible     Prostate    Adenocarcinoma NOS.
4 F 62 Mandible     Breast    
Poorly-differentiated 
adenocarcinoma
5 F 75 Mandible     Thyroid    Follicular carcinomar
6 M 19 Maxilla Soft part    Alveolar sarcoma
7 M 38 Maxilla Prostate Adenocarcinoma NOS
8 M 32 Maxilla Prostate Adenocarcinoma NOS
9 F 36 Maxilla Breast Ductal carcinoma
10 F 16 Mandible     Soft part Myxoid fibrosarcoma
 Key:   NOS - not otherwise specified.
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RESULTS
The sample was as follows, based on our data:
DISCUSSION
Malignant gnathic bone neoplasms, particularly 
of the mandible, have a low incidence compared to 
human tumors in general (less than 0.7%). These ne-
oplasms cause significant morphological, functional 
and esthetic alterations due to their progression, local 
and regional involvement, and the need for aggres-
sive therapy. They may be divided into primary and 
secondary or metastatic malignancies. There are three 
histological origins: tumors derived from odontogenic 
tissues, those derived from skeletogenic connective 
tissues, and those derived from non-odontogenic and 
non-skeletogenic tissues.2
Gnathic bones are generally uncommon sites for 
metastases; their involvement may, however, be higher 
than the usually reported frequency in the literature.4
Rutsatz et al.5 (1990) reported 1,008 patients 
with malignancies of the face (soft parts and bone) 
and mouth in a 35-year period, and found only five 
patients (0.5%) with metastases to the mandible. These 
were described as distance metastases of tumors from 
various primary sites.
Pruckmayer et al.6 undertook a major retrospec-
tive study of 763 patients that presented non-specific 
pain in the mandible; of these, only nine patients (1.2%) 
had metastases to the mandible. These authors noted 
that pain was an important sign in the investigation, 
and that gnathic bone metastases indicate widespread 
disease,4,6 as seen in our sample.
There were three cases in the second and fourth 
decades of life (30%), and two cases in the seventh and 
eighth decades of life (20%). The age ranged from 13 
to 75 years (median - 43 years).
Van der Waal et al.7 analyzed a sample of 1,537 
mouth cancer cases, of which 24 were metastatic tu-
mors; the age distribution was similar to that of our sam-
ple, ranging from 8 to 90 years (median - 60 years).
D’Silva et al.8 commented the age and sex distri-
bution of maxillary metastases in their sample, stating 
that females have twice the number of metastases 
compared to males. The age groups in that study, from 
higher to lower occurrence, were 31 to 40 years and 
71 to 80 years, different from our findings.
The mandible and the maxilla were equally invol-
ved by bone metastases (5 cases each), which is diffe-
rent from data in the literature, which indicates an 80% 
prevalence of bone metastases in the mandible.4,9
D’Silva et al.8 studied 114 cases of maxillary 
metastases retrospectively, and reported that the pre-
ference for the mandibular bone was more evident in 
females, rather than males.
Hirshberg et al.10 studied 390 cases of gnathic 
bone metastases, of which 316 cases (81%) were located 
in the mandible, and only 58 cases (14%) were located 
in the maxilla; involvement of both bones was seen in 
21 patients (5.4%).
The metastatic tumor histology in our sample 
revealed papillary adenocarcinoma (one case), poorly-
differentiated adenocarcinoma (one case), adenocarci-
noma not otherwise specified (three cases), follicular 
carcinoma (two cases), myxoid fibrosarcoma (one 
Figure 1. Clinical aspect of mandibular metastasis of a prostatic 
adenocarcinoma.
Figure 2. Clinical aspect of mandibular metastasis of a breast ade-
nocarcinoma.
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case), alveolar sarcoma (one case) and ductal carci-
noma (one case)
Van der Waal et al.7 have stated that the adeno-
carcinoma is the main histological type of gnathic bone 
metastases from a variety of primary tumors, which is 
in agreement with the data from our sample.
In our sample, the sites of primary malignancies 
giving rise to distance metastases to gnathic bones were 
the thyroid gland (3 cases) and the prostate (3 cases) 
as the three most common sites, followed by the breast 
(2 cases) and soft part sarcomas (2 cases).
Soft part metastases to the mouth are uncommon, 
but of significant occurrence. The literature cites the 
breast, the thyroid and the lung as the most common 
sites responsible for hematogenic distance metastases 
to gnathic bones.3,11,12 Other sites, such as the prostate, 
soft parts and the kidneys, are considered as rare;3 still 
other sites mentioned below are extremely rare.
Piattelli et al.13 investigated 390 mouth cancer 
cases and found 22 cases (5.6%) of gnathic bone me-
tastases, of which the prostate was the primary site. 
These authors underline that the prostate is a rare 
site for primary malignancies giving rise to maxillary 
metastases.
Stavropoulos and Ord14 reported a case of a 
female patient with breast cancer that metastasized to 
the mandibular condyle; there ensued a pathological 
fracture that was initially diagnosed and treated as a 
non-neoplastic manifestation of the temporo-mandi-
bular joint.
Porter et al.15 reported a case of malignant tera-
tomas of the testicle that metastasized to both mandi-
bular condyles. The diagnosis was only made because 
the patient complained of intense pain in the affected 
sites. Schumacher and Rohde16 reported a rare case of 
vulvar carcinoma that metastasized to the mandible. 
Yanagi et al.11 reported a case of a male patient aged 59 
years with a malignant pheocromocytoma - a primary 
tumor o the right adrenal gland - that metastasized to 
the mandible. Ogunsalu and Samith17 reported a case 
of a right adrenal neuroblastoma in a male patient 
aged 21 years that metastasized to the mandible. Rare 
sites, such as soft parts (sarcomas) and primary tumors 
from other bones rarely metastasize to the mandible 
and maxilla.4
There are cases of neck soft part neoplasms 
that grow by extension into adjacent structures; these 
tumors may simulate a primary tumor in radiological 
exams. Captier et al.18 reported a case of a child aged 
10 years that presented a tumor on the horizontal ramus 
of the mandible that extended to the submandibular 
area. Radiology suggested a primary bone neoplasm, 
but histopathology revealed a soft part synovial sarcoma 
of the neck that invaded the mandible and the floor 
of the mouth; this is an extremely rare mesenchymal 
tumor of the head in children.
The literature states that in about 30% of cases 
of patients with gnathic bone metastases, the primary 
tumor is asymptomatic and not diagnosed.9 No hidden 
primary tumors with existing metastases were observed 
in our sample.
The prognosis of gnathic bone metastatic neo-
plasms is poor, resulting from the pathophysiology of 
the primary tumor, which generally is highly aggressive; 
these metastases occur at an advanced stage of the 
disease, and may be associated with paraneoplastic 
syndromes.
CONCLUSION
1. Gnathic bone metastases are rare and may 
affect any age group and both sexes, with equal pre-
valence in the mandible and maxilla.
2. The thyroid gland and the prostate appear to 
be the most frequent primary sites for distance metas-
tases to gnathic bones. The adenocarcinoma appears to 
be the most common histological type in metastases.
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